Contrast Media and Reactions Practice Questions

Q: All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Mannitol. **Explanation:** Contrast-Induced Nephropathy (CIN) is a significant risk in patients with reduced GFR. The goal of management is to minimize renal vasoconstriction and oxidative stress. **Why Mannitol is the Correct Answer:** Historically, diuretics like **Mannitol** and Furosemide were thought to "flush" the kidneys. However, clinical trials (such as the PRINCE study) have shown that Mannitol is **ineffective** and may actually be **harmful**. It can cause osmotic diuresis leading to dehydration and further renal vasoconstriction, potentially worsening the risk of CIN. Therefore, it is no longer recommended. **Analysis of Other Options:** * **N-acetyl cysteine (NAC):** An antioxidant that scavenges free radicals and induces vasodilation. While its efficacy is debated in recent large trials (PRESERVE), it is still traditionally used in protocols to prevent CIN due to its low cost and safety profile. * **Fenoldopam:** A selective dopamine D1 receptor agonist that causes renal vasodilation. Though not routinely used due to cost and mixed evidence, it is pharmacologically intended to increase renal blood flow. * **Low Osmolar Contrast Media (LOCM):** High osmolar contrast (HOCM) is highly nephrotoxic. Switching to LOCM (e.g., Iohexol) or Iso-osmolar contrast (e.g., Iodixanol) significantly reduces the risk of CIN in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most effective preventive measure:** Adequate **Pre-procedure Hydration** with 0.9% Normal Saline is the gold standard. * **Definition of CIN:** An increase in serum creatinine of >0.5 mg/dL or >25% from baseline within 48–72 hours of contrast administration. * **Metformin:** Must be withheld for 48 hours *after* the procedure to avoid lactic acidosis if renal failure occurs.

Q: What type of radiological contrast agent is preferred for demonstrating a tracheoesophageal fistula?

Low osmolar iodine contrast. ### Explanation The primary concern when evaluating a **Tracheoesophageal Fistula (TEF)** is the high risk of contrast aspiration into the lungs or leakage into the mediastinum. **Why Low Osmolar Iodine Contrast (LOCM) is correct:** LOCM (e.g., Iohexol or Iopamidol) is the preferred agent because it is **water-soluble** and **non-ionic**. If aspirated, LOCM is significantly less irritating to the pulmonary mucosa compared to other agents. It does not cause the severe chemical pneumonitis associated with barium, nor the life-threatening pulmonary edema associated with high-osmolar agents. **Analysis of Incorrect Options:** * **A. High Osmolar Iodine Contrast (HOCM):** These agents (e.g., Gastrografin) are hypertonic. If aspirated, they draw fluid into the alveoli via osmosis, leading to **acute pulmonary edema**, which can be fatal. * **C. Gadolinium-DTPA:** This is an MRI contrast agent. It is not used for fluoroscopic swallow studies or for demonstrating fistulous tracts in routine radiography. * **D. Thick Barium Sulfate:** Barium is inert but non-absorbable. If aspirated into the lungs or leaked into the mediastinum through a fistula, it can cause a severe **foreign body granulomatous reaction** and permanent scarring (fibrosis). **Clinical Pearls for NEET-PG:** * **Gold Standard for TEF:** Fluoroscopic swallow study using **LOCM**. * **Barium Contraindication:** Never use barium if a **perforation** or **fistula** is suspected (risk of mediastinitis/peritonitis). * **Water-Soluble Contraindication:** Avoid HOCM (Gastrografin) if **aspiration** is suspected; use LOCM instead. * **Safe Sequence:** In many GI studies, a water-soluble agent is used first to rule out a leak; if negative, barium may follow for better mucosal detail.

Q: Which of the following conditions is associated with contrast nephropathy?

Diabetes nephropathy. **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function (an increase in serum creatinine by >25% or >0.5 mg/dL) occurring within 48–72 hours of intravascular contrast administration. **Why Diabetes Nephropathy is the Correct Answer:** Diabetes mellitus, particularly when associated with pre-existing renal insufficiency (**Diabetic Nephropathy**), is the **single most significant independent risk factor** for developing CIN. The pathophysiology involves contrast-induced renal vasoconstriction leading to medullary ischemia and direct tubular cytotoxicity. In diabetic patients, the baseline oxidative stress and impaired vasodilatory capacity of the renal vasculature significantly potentiate these effects. **Analysis of Incorrect Options:** * **B, C, and D (Hypertension, Malignant Hypertension, Hypertensive Glomerulosclerosis):** While chronic hypertension can lead to renal damage, it is generally considered a secondary risk factor. Hypertension only significantly increases the risk of CIN if it has already progressed to significant **chronic kidney disease (CKD)** with a reduced Glomerular Filtration Rate (GFR). Diabetic nephropathy carries a much higher relative risk compared to hypertensive nephrosclerosis alone. **High-Yield Clinical Pearls for NEET-PG:** * **Most Important Risk Factor:** Pre-existing renal insufficiency (low GFR). * **Most Effective Prophylaxis:** Intravenous hydration with **Isotonic Saline (0.9% NaCl)** or Sodium Bicarbonate before and after the procedure. * **Metformin Warning:** Metformin does not cause CIN, but if CIN occurs, Metformin can accumulate and cause **Lactic Acidosis**. It should be withheld for 48 hours after contrast administration. * **Contrast Choice:** Non-ionic, **iso-osmolar** contrast media (e.g., Iodixanol) carry the lowest risk for nephropathy.

Q: Which of the following investigations must be performed before administering contrast to a patient?

Kidney function test (KFT). **Explanation:** The administration of iodinated contrast media (used in CT scans and angiography) poses a significant risk of **Contrast-Induced Nephropathy (CIN)**. CIN is defined as an acute decline in renal function (increase in serum creatinine by >0.5 mg/dL or >25% from baseline) within 48–72 hours of contrast exposure. Therefore, assessing the **Kidney Function Test (KFT)**—specifically **Serum Creatinine** and the **estimated Glomerular Filtration Rate (eGFR)**—is mandatory to screen for pre-existing renal impairment, which is the strongest risk factor for CIN. **Analysis of Incorrect Options:** * **Liver Function Test (LFT):** While some contrast agents are excreted via the biliary system, hepatic impairment does not significantly increase the risk of acute toxicity or contrast reactions. * **Urine Specific Gravity:** This measures urine concentration and hydration status but is an unreliable indicator of the kidney's ability to clear contrast media compared to eGFR. * **Serum Electrolytes:** While important for general patient management, electrolyte imbalances are not a direct contraindication to contrast nor a primary predictor of contrast-induced injury. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Threshold:** Contrast is generally considered safe if **eGFR >60 mL/min/1.73m²**. Caution is required if eGFR is between 30–60, and it is generally avoided (unless emergency) if **eGFR <30**. * **Prevention:** The most effective preventive measure for CIN is **intravenous hydration** with 0.9% Normal Saline before and after the procedure. * **Metformin:** In patients with renal impairment, Metformin should be withheld for 48 hours after contrast administration to prevent **Lactic Acidosis**. * **MRI Contrast:** For Gadolinium-based agents, the concern is **Nephrogenic Systemic Fibrosis (NSF)** in patients with severe renal failure.

Q: All of the following are true about iodinated intravascular contrast media except –

They are used in magnetic resonance imaging. **Explanation:** The correct answer is **D**. Iodinated contrast media are specifically designed for X-ray-based imaging modalities, not Magnetic Resonance Imaging (MRI). **1. Why Option D is the correct (false) statement:** Iodinated contrast agents work by increasing the attenuation of X-ray beams due to the high atomic number of Iodine ($Z=53$). MRI does not use X-rays; instead, it utilizes magnetic fields and radiofrequency pulses. The standard contrast agents for MRI are **Gadolinium-based contrast agents (GBCAs)**, which are paramagnetic and work by altering the relaxation times ($T1$ and $T2$) of nearby water protons. **2. Analysis of incorrect (true) options:** * **Option A:** Digital Subtraction Angiography (DSA) uses iodinated contrast injected into vessels to visualize lumen morphology by "subtracting" the overlying bone and soft tissue densities. * **Option B:** Iodine is highly **radio-opaque** (appears white on imaging) because it absorbs X-ray photons, providing the necessary contrast against blood and soft tissues. * **Option C:** These agents can cause **idiosyncratic (anaphylactoid) reactions**, ranging from mild urticaria to life-threatening bronchospasm and shock. Unlike true allergies, these are often not IgE-mediated. **Clinical Pearls for NEET-PG:** * **Contrast-Induced Nephropathy (CIN):** A key risk factor; defined as an increase in serum creatinine >0.5 mg/dL or >25% from baseline within 48–72 hours of administration. * **Pre-medication:** For patients with a history of prior reactions, use corticosteroids (e.g., Prednisolone) and H1 blockers. * **Osmolality:** Non-ionic, low-osmolar contrast media (LOCM) are preferred over high-osmolar media (HOCM) as they are safer and better tolerated. * **MRI Exception:** While rare, **Hepatobiliary agents** (like Primovist) are used in MRI, but they are still Gadolinium-based, never iodinated.

Q: Which element is the basis for contrast agents commonly used in CT scans?

Iodine. **Explanation:** The correct answer is **Iodine (Option C)**. **Why Iodine is the Correct Choice:** The primary mechanism of contrast in CT scans is the attenuation (absorption) of X-rays. Iodine has a high **atomic number (Z = 53)**, which makes it highly effective at absorbing X-ray photons via the photoelectric effect. When injected intravenously or taken orally, iodinated contrast agents increase the radiodensity of blood vessels and organs, making them appear "bright" (hyperdense) on the scan. This allows for the differentiation of vascular structures from surrounding soft tissues. **Analysis of Incorrect Options:** * **Gadolinium (A):** This is the gold standard contrast agent for **MRI**, not CT. It is a paramagnetic substance that alters the relaxation times of nearby water protons to enhance image signal. * **Technetium (B):** Specifically Technetium-99m, this is a radioisotope used as a tracer in **Nuclear Medicine** (e.g., bone scans, SPECT). It emits gamma radiation rather than absorbing X-rays. * **Chromium (D):** While radioactive Chromium-51 was historically used in specialized hematology tests (like red cell mass studies), it has no role as a routine radiological contrast agent. **High-Yield Clinical Pearls for NEET-PG:** 1. **Barium Sulfate:** Used for GI studies (fluoroscopy/CT) but is contraindicated if bowel perforation is suspected (use water-soluble iodinated contrast like Gastrografin instead). 2. **Adverse Reactions:** Iodinated contrast can cause **Contrast-Induced Nephropathy (CIN)**. Always check serum creatinine/eGFR in high-risk patients (diabetics, elderly). 3. **Metformin Rule:** Patients on Metformin should ideally withhold the drug for 48 hours after receiving iodinated contrast to prevent lactic acidosis if renal function is impaired.

Q: Which of the following contrast media agents is least nephrotoxic?

Iodixanol. ### Explanation The primary determinant of contrast-induced nephropathy (CIN) is the **osmolality** of the contrast medium. High-osmolality agents cause renal vasoconstriction and direct tubular toxicity. **1. Why Iodixanol is Correct:** Iodixanol is a **non-ionic dimer** and is classified as an **Iso-osmolar Contrast Medium (IOCM)**. Its osmolality (approx. 290 mOsm/kg) is equal to that of human blood. Because it is isotonic to plasma, it causes the least amount of osmotic stress on the renal tubules, making it the least nephrotoxic option among those listed, especially in high-risk patients (e.g., diabetics with pre-existing renal impairment). **2. Analysis of Incorrect Options:** * **Diatrizoate & Metrizoate (Option B & C):** These are **Ionic Monomers** classified as **High-Osmolar Contrast Media (HOCM)**. Their osmolality is 5–8 times that of plasma (1500–2000 mOsm/kg). They carry the highest risk of nephrotoxicity and adverse allergic reactions. * **Ioxaglate (Option D):** This is an **Ionic Dimer** classified as a **Low-Osmolar Contrast Medium (LOCM)**. While safer than HOCM, its ionic nature and higher osmolality compared to Iodixanol make it more nephrotoxic than iso-osmolar agents. **3. NEET-PG High-Yield Pearls:** * **Classification by Osmolality:** * **HOCM:** Diatrizoate, Metrizoate, Iothalamate. * **LOCM:** Iohexol, Iopromide, Ioversol, Ioxaglate (Ionic). * **IOCM:** Iodixanol (Safest for kidneys). * **CIN Prevention:** The most effective preventive measure is **adequate hydration** (Normal saline) before and after the procedure. * **Risk Factor:** A baseline Serum Creatinine >1.5 mg/dL or eGFR <60 mL/min increases the risk of CIN. * **Metformin Rule:** Metformin should be withheld for 48 hours *after* contrast administration to prevent lactic acidosis if renal failure occurs.

Q: Worsening of kidney function in contrast nephropathy is best evaluated with?

High serum creatinine. **Explanation:** **Contrast-Induced Nephropathy (CIN)** is defined as an acute impairment of renal function following the intravascular administration of iodinated contrast media. **1. Why High Serum Creatinine is Correct:** Serum creatinine is the standard biochemical marker used to monitor glomerular filtration rate (GFR). In CIN, the contrast medium causes renal vasoconstriction and direct tubular toxicity, leading to a decrease in GFR. This results in a **rise in serum creatinine**, typically peaking within 3 to 5 days after contrast administration. A common diagnostic criterion for CIN is an absolute increase in serum creatinine of **≥0.5 mg/dL** or a relative increase of **≥25%** from the baseline value within 48–72 hours. **2. Why Incorrect Options are Wrong:** * **Low Serum Creatinine:** A decrease in creatinine would indicate improving renal function or muscle wasting, which is the opposite of what occurs in nephropathy. * **High/Low Serum Bilirubin:** Bilirubin is a marker of hepatobiliary function and hemolysis. It has no physiological correlation with contrast-induced renal injury or glomerular filtration. **Clinical Pearls for NEET-PG:** * **Risk Factor:** The single most important risk factor for CIN is pre-existing **chronic kidney disease (CKD)**, especially when associated with Diabetes Mellitus. * **Prevention:** The most effective preventive strategy is **adequate hydration** (usually with 0.9% Normal Saline) before and after the procedure. * **Contrast Choice:** Using **Non-ionic, Low-osmolar (LOCM)** or **Iso-osmolar** contrast media reduces the risk of CIN compared to high-osmolar agents. * **Metformin Note:** Metformin does not cause CIN, but if CIN occurs, metformin can accumulate and cause **lactic acidosis**. It should be withheld for 48 hours after the procedure in high-risk patients.

Question 1

All of the following are used in a patient with decreased renal function (reduced GFR) to avoid contrast nephropathy except?

Accepted Answer

Mannitol

Answer

N-acetyl cysteine

Answer

Fenoldopam

Answer

Low osmolar contrast media (LOCM)

Question 2

What type of radiological contrast agent is preferred for demonstrating a tracheoesophageal fistula?

Accepted Answer

Low osmolar iodine contrast

Answer

High osmolar iodine contrast

Answer

Gadolinium-DTPA

Answer

Thick barium sulfate suspension

Question 3

Which of the following conditions is associated with contrast nephropathy?

Accepted Answer

Diabetes nephropathy

Answer

Hypertension

Answer

Malignant hypertension

Answer

Hypertensive glomerulosclerosis

Question 4

Which of the following investigations must be performed before administering contrast to a patient?

Accepted Answer

Kidney function test (KFT)

Answer

Liver function test (LFT)

Answer

Urine specific gravity

Answer

Serum electrolytes

Question 5

All of the following are true about iodinated intravascular contrast media except –

Accepted Answer

They are used in magnetic resonance imaging

Answer

They are used in digital subtraction angiography

Answer

They are radio opaque

Answer

They can cause anaphylactic reactions

Question 6

Nephrogenic systemic fibrosis is associated with:

Accepted Answer

Gadolinium administration in patients with chronic renal failure

Answer

Genetic disease with selenium deficiency

Answer

Chromium toxicity

Answer

HIV association

Question 7

Intravenous pyelogram (IVP) should be cautiously performed in which of the following conditions?

Accepted Answer

Multiple myeloma

Answer

Bone secondaries

Answer

Neuroblastoma

Answer

Leukemia

Question 8

Which element is the basis for contrast agents commonly used in CT scans?

Accepted Answer

Iodine

Answer

Gadolinium

Answer

Technetium

Answer

Chromium

Question 9

Which of the following contrast media agents is least nephrotoxic?

Accepted Answer

Iodixanol

Answer

Diatrizoate

Answer

Metrizoate

Answer

Ioxaglate

Question 10

Worsening of kidney function in contrast nephropathy is best evaluated with?

Accepted Answer

High serum creatinine

Answer

Low serum creatinine

Answer

High serum bilirubin

Answer

Low serum bilirubin

Contrast Media and Reactions — MCQs

Contrast Media and Reactions — MCQs

On this page

Practice by Chapter

Want unlimited practice?